Tango Therapeutics, Inc.
TNGX
Classement en actions
#4544
Tango Therapeutics, Inc. is a biotechnology firm dedicated to the research and... Tango Therapeutics, Inc. is a biotechnology firm dedicated to the research and development of innovative cancer treatments. Their primary therapeutic candidate, TNG908, is a synthetic lethal small molecule designed to inhibit protein arginine methyltransferase 5 (PRMT5). This compound is currently being advanced as a potential therapy for cancers characterized by methylthioadenosine phosphorylase (MTAP) deletions. Additionally, their pipeline includes an Ubiquitin-specific protease 1 (USP1) inhibitor targeting BRCA1 or BRCA2-mutant cancers, and a program known as 'Target 3' which addresses STK11-mutant cancers. Tango Therapeutics maintains a strategic alliance with Gilead Sciences, Inc., focused on the identification, advancement, and commercialization of a diverse array of cancer therapies. Established in 2017, the company's operations are headquartered in Cambridge, Massachusetts.
Prix de l'action
$27.18
Dernière synchronisation: 2026-07-31
Capitalisation boursière
$3.38B
Changement (1 jour)
-1.41%
Changement (1 an)
202.34%
Pays
US
Échange Tango Therapeutics, Inc. (TNGX)
Catégorie
Healthcare
Historique des divisions d’actions pour Tango Therapeutics, Inc. (TNGX)
L’action Tango Therapeutics, Inc. (symbole : TNGX) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Oct 21, 2026.
Une action TNGX achetée avant le Oct 21, 2026 équivaudrait aujourd’hui à 0 actions TNGX.
La division la plus récente a eu lieu le Oct 21, 2026.
Une action TNGX achetée avant le Oct 21, 2026 équivaudrait aujourd’hui à 0 actions TNGX.
Liste des divisions d’actions
| Année | Division | Multiplicateur | Multiplicateur cumulatif |
|---|---|---|---|
| Pas assez de données pour les dates fournies. | |||
Divisions d’actions d’entreprises similaires ou concurrentes
| Entreprise | Nombre de divisions d’actions | Multiplicateur cumulatif | Pays |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
NL
|
|
| 0 | - |
CH
|